abstract |
The present invention provides a method for normalizing corneal endothelial cells. More specifically, the present invention provides a culture normalizing agent for corneal endothelial cells containing a fibrosis inhibitor. Specifically, the present invention provides a culture normalizing agent comprising a transforming growth factor (TGF) β signal inhibitor. The present invention also provides a medium for normal culture of corneal endothelial cells, comprising the culture normalizing agent of the present invention and a culture component of corneal endothelium. The present invention further provides a method for normally culturing corneal endothelial cells, comprising the step of culturing corneal endothelial cells using the culture normalizing agent of the present invention or the medium of the present invention. |